Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024623 (
gastric cancer
)
36,219
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Irsogladine Maleate
intensifies the degree of intercellular contact so we expected that a combination of
Irsogladine Maleate
and UFT would cause tumor-reducing effect and normalization of the malignant cells. A combination of
Irsogladine Maleate
and UFT was administered to 2 patients with inoperable
gastric cancer
(Case 1: An 83-year-old male: Borrmann type I, Case 2: A 93-year-old female: A relatively wide early
gastric cancer
), marked tumor reduction was obtained in both cases. The doses administered were 4 mg/day of
Irsogladine Maleate
and 200 mg/day of UFT.
...
PMID:2 cases of gastric-cancer remarkably reduced with a combined dosage of irsogladine maleate preparation and uft. 2160 13
